Companies / Yumanity Therapeutics, Inc.
Yumanity Therapeutics, Inc.
KAKANT, YMTXCIK 1445283
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | Bartoszek Raymond J. Director | Grant Grant or award | Common Stock | $4.34M | +376K +108.25% | 722,875 | low |
| May 1, 2024 | Bartoszek Raymond J. Director | Other Other (per filing) | Common Stock | $500.0K | +904K +107.05% | 1,748,473 | low |
| Dec 16, 2022 | Foote Marion R Director | Grant Grant or award | Common Stock | $250.0K | +22K +18.48% | 138,761 | low |
| Dec 16, 2022 | Philips Craig W. Executive | Grant Grant or award | Common Stock | $100.0K | +9K +35.18% | 33,272 | low |
| Dec 16, 2022 | Iadonato Shawn CEO | Grant Grant or award | Common Stock | $100.0K | +9K +1.31% | 668,986 | low |
| Jun 23, 2025 | Philips Craig W. Executive | Exercise Option exercise | Common Stock | $81.0K | +225K +370.00% | 285,811 | low |
| Jun 23, 2025 | Guillaudeux Thierry Executive | Exercise Option exercise | Common Stock | $81.0K | +225K +1037.06% | 246,696 | low |
| Jun 23, 2025 | Baker Keith Executive | Exercise Option exercise | Common Stock | $81.0K | +225K +1332.94% | 241,880 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| KA | common | 49461C102 |